trenzyme - offering a wide range of high quality proteins and cell lines off-the-shelf

Catalog Products

Now available in our Webshop

Since 2000, trenzyme has developed a wide range of proteins and cell lines for a variety of research applications, including drug discovery. Our highly skilled and experienced scientific experts provide fast and reliable services to leading global companies, ranging from academia and small biotechs to big pharmaceutical companies.
Facilitating the fast access to high quality proteins and cell lines to support your daily work in research and development, trenzyme provides a continuously growing catalog of off-the-shelf recombinant proteins and cell lines in our webshop Reliable results at highest quality standards and with maximum efficiency will save you valuable research time and money and accelerate your innovation.

Catalog Proteins

Viral Proteins and other Target Classes

Catalog Cell Lines

Assay Cell Lines, Production Cell Lines and more

Find recombinant SARS-CoV-2 Proteins in our Webshop

In our webshop you will find ready-to-use SARS-CoV-2 (COVID-19) proteins like SARS-COV-2 Spike S, SARS-CoV-2 Spike S1 RBD, Nucleocapsid (N) protein, Proteinase 3 CL-Mpro, M protein, Envelope (E) protein and other relevant proteins that are associated with Coronavirus infection like hACE2 protein. In addition, we offer a wide range of important SARS-CoV-2 Variants (Spike Mutant Proteins). All proteins can be ordered from stock and have very short delivery times.



Spike S1 (RBD)

Search for various variants of the SARS-CoV-2 (COVID-19) Spike S1 (RBD) protein in our webshop

S trimer

Find different variants of the Spike protein, stabilized trimer, of SARS-CoV-2 (COVID-19) in our webshop

Spike Variants

Variety of SARS-CoV-2 Spike Variants (Indian / U.K. / South Africa / Brazil and other variants) available

human ACE2

Different human ACE-2 protein variants,  one of the most important components for Coronavirus research, available in our webshop

Further Corona Proteins

Find further SARS-CoV-2 proteins: SARS-CoV-2 Proteinase 3 CL-Mpro, M protein, E protein and N protein

cGMP cell line for SARS-CoV-2 S1 (RBD)

cGMP-compliant production cell line for the SARS-CoV-2 Spike S1 (RBD) available on request

Relevant Publications

Lactoferrin binding to Sars-CoV-2 Spike glycoprotein protects host from infection, inflammation and iron dysregulation., 17 May 2022, PREPRINT (Version 1) available at Research Square (2022)

Cutone A, Rosa L, Bonaccorsi di Patti MC, Iacovelli F, Conte MP, Ianiro G, Romeo A, Campione E, Bianchi L, Valenti P, Falconi M, and Musci G

Read more

High antibody and reduced cellular response in children up to one year after SARS-CoV-2 infection, 15 February 2022, PREPRINT (Version 1) available at Research Square (2022)

Jacobsen EM, Fabricius D, Class M, Topfstedt F, Lorenzetti R, Janowska I, Schmidt F, Staniek J, Zernickel M, Stamminger T, Dietz A, Zellmer A, Hecht M, Rauch P, Blum C, Ludwig C, Jahrsdörfer B, Schrezenmeier H, Heeg M, Mayer B, Seidel A, Groß R, Münch J, Bode S, Strauss G, Renk H, Elling R, Stich M, Voll R, Tönshoff B, Franz A, Henneke P, Debatin K-M, Rizzi M, and Janda A

Read more

Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays. Clin Transl Immunol, 11: e1369 (2022)

Sander I, Kespohl S, Zahradnik E, Göcke P, Hosbach I, Herrmann BL, Brüning T, and Raulf M

Read more

Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG. iScience. 2022 Jan 21;25(1):103659. doi: 10.1016/j.isci.2021.103659. Epub 2021 Dec 20. PMID: 34957380; PMCID: PMC8686444. (2022)

Winklmeier S, Eisenhut K, Taskin D, Rübsamen H, Gerhards R, Schneider C, Wratil PR, Stern M, Eichhorn P, Keppler OT, Klein M, Mader S, Kümpfel T, and Meinl E

Read more

Development and validation of novel kit for quantification of SARS-CoV-2 antibodies on clinical samples, Journal of Virological Methods, Volume 300 (2022)

Kumari S, Raina A, Chandra D, Gupta N, Dey N, Bhardwaj A K, Anthwal A, Mishra V C, Raina V, Tiwari A K, Setia R, and Bhatia A S

Read more

Fluorescence signatures of SARS CoV-2 spike S1 proteins and an human ACE-2: excitation-emission maps and fluorescence lifetimes (2022)

Grzesiak J, Fellner L, Grünewald K, Kölbl C, Walter A, Horlacher R, and Duschek F

Read more

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody. Sci Rep 11, 3318 (2021)

Valenzuela Nieto G, Jara R, Watterson D, Modhiran N, Amarilla AA, Himelreichs J, Khromykh AA, Salinas-Rebolledo C, Pinto T, Cheuquemilla Y, Margolles Y, López González del Rey N, Miranda-Chacon Z, Cuevas A, Berking A, Deride C, González-Moraga S, Mancilla H, Maturana D, Langer A, Toledo JP, Müller A, Uberti B, Krall P, Ehrenfeld P, Blesa J, Chana-Cuevas P, Rehren G, Schwefel D, Fernandez LA, and Rojas-Fernandez A

Read more

SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study. Viruses 2021, 13, 1143. (2021)

Belogiannis K, Florou VA, Fragkou PC, Ferous S, Chatzis L, Polyzou A, Lagopati N, Touliatou A, Vassilakos D, Kittas C, Tzioufas AG, Tsiodras S, and Gorgoulis V

Read more

Ultra-sensitive and fast optical detection of the spike protein of the SARS-COV-2 using AgNPs/SiNWs nanohybrid based sensors (2021)

Daoudi K, Ramachandran K, Alawadhi H, Boukherroub R, Dogheche E, El Khakani MA, and Gaidi M

Read more

Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro (2021)

Gauhar A, Privezentzev CV, Demydchuk M, Gerlza T, Rieger J, Kungl AJ, Walsh FJ, Rutkowski JL, and Stocki P

Read more

SARS-CoV-2 infects lung epithelial cells and induces senescence and an inflammatory response in patients with severe COVID-19 (2021)

Evangelou K, Veroutis D, Foukas PG, Paschalaki K, Lagopati N, Dimitriou M, Papaspyropoulos A, Hazapis O, Polyzou A, Havaki S, Kotsinas A, Kittas C, Tzioufas AG, de Leval L, Vassilakos D, Tsiodras S, Karakasiliotis I, Barnes PJ, and Gorgoulis VG

Read more

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. (2021)

Barros-Martins J, Hammerschmidt SI, Cossmann A, Odak I, Stankov MV, Morillas Ramos G, Dopfer-Jablonka A, Heidemann A, Ritter C, Friedrichsen M, Schultze-Florey C, Ravens I, Willenzon S, Bubke A, Ristenpart J, Janssen A, Ssebyatika G, Bernhardt G, Münch J, Hoffmann M, Pöhlmann S, Krey T, Bošnjak B, Förster R, and Behrens GMN

Read more

Novel surrogate virus neutralization test reveals low serum neutralizing anti-SARS-CoV-2-S antibodies levels in mildly affected COVID-19 convalescents (2020)

Bošnjak B, Stein SC, Willenzon S, Cordes AK, Puppe W, Bernhardt G, Ravens I, Ritter C, Schultze-Florey CR, Gödecke N, Martens J, Kleine-Weber H, Hoffmann M, Cossmann A, Yilmaz M, Pink I, Hoeper MM, Behrens GMN, Pöhlmann S, Blasczyk R, Schulz TF, and Förster R

Read more

Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals. Infect Dis Ther 9, 837–849. (2020)

Behrens GMN, Cossmann A, Stankov MV, Schulte B, Streeck H, Förster R, Bosnjak B, Willenzon S, Boeck AL, Tran AT, Thiele T, Graalmann T, Kayser MZ, Zychlinsky Scharff A, Dopfer C, Horke A, Pink I, Witte T, Wetzke M, Ernst D, Jablonka A, and Happle C

Read more

Population-wide evolution of SARS-CoV-2 immunity tracked by a ternary immunoassay (2020)

Emmenegger M, De Cecco E, Lamparter D, Jacquat R, Ebner D, Schneider MM, Condado Morales I, Schneider D, Doğançay B, Guo J, Wiedmer A, Domange J, Imeri M, Moos R, Zografou C, Trevisan C, Gonzalez-Guerra A, Carrella A, Dubach IL, Xu C, Meisl G, Kosmoliaptsis V, Malinauskas T, Burgess-Brown N, Owens R, Mongkolsapaya J, Hatch S, Screaton GR, Schubert K, Huck JD, Liu F, Pojer F, Lau K, Hacker D, Probst-Mueller E, Cervia C, Nilsson J, Boyman O, Saleh L, Spanaus K, von Eckardstein A, Schaer DJ, Ban N, Tsai CJ, Marino J, Schertler GFX, Gottschalk J, Frey BM, Reimann R, Hornemann S, Ring AM, Knowles TPJ, Xenarios I, Stuart DI, and Aguzzi A

Read more

Looking for a customized solutions for your recombinant protein production or cell line development project? As research service provider, we offer a wide range of highly customized services for the development of  cell lines, stem cells and the recombinant protein production for your project.

Reinhold Horlacher, PhD

Reinhold Horlacher, PhD

Managing Director & CSO

We would be happy to provide you with support on your protein or cell line research project. Let us know your questions and requests, our scientific experts will reply shortly.

Get In Contact With Our Scientific Experts

    By submitting this form, I consent to trenzyme GmbH receiving and processing my data in order to process my inquiry. My consent is voluntary and I may revoke this consent at any time without providing any reasons, e.g. by sending an email to privacy(at) with effect for the future. Further notices on data processing can be found in our privacy policy.